About
Passive Imaging Medical Systems (PIMS) develops infrared-based endoscopy products designed for the early detection and diagnosis of colorectal cancer, gastric cancer, and other diseases of the GI tract. The companys first product, an infrared detector device, is a patented, add-on imaging camera designed to improve physicians ability to detect GI tract lesions by providing an objective, radar-like tool. The PIMS device offers physicians an additional field of view in the infrared range. Irregular tissue radiates differently than normal tissue and can be visualized by the computer, allowing a specific spectrographic infrared signature to be immediately analyzed for reliable early diagnosis.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is the primary focus of PIMS's technology?
- PIMS develops infrared-based endoscopy products for the early detection and diagnosis of colorectal cancer, gastric cancer, and other GI tract diseases.
- What is the status of PIMS as of August 2015?
- PIMS is inactive and ceased to operate in August 2015.
- When was PIMS founded?
- PIMS was founded in January 2008.
- What is PIMS's first product?
- PIMS's first product is a patented, add-on infrared detector imaging camera designed to improve the detection of GI tract lesions.
- How does the PIMS device assist in diagnosis?
- The PIMS device provides an additional field of view in the infrared range, allowing irregular tissue to be visualized and analyzed for a spectrographic infrared signature, aiding in early diagnosis.
- Where is PIMS headquartered?
- PIMS is headquartered in Haifa, Israel.
- What is the employee count for PIMS?
- PIMS has 6 employees.
- Who are the founders of PIMS?
- The founders of PIMS are Ronnie Klein and Yaniv Cohen.